System, device, composition and method for treating and preventing avascular or osteonecrosis

• US 20030135214A1
• Filed: 01/15/2002
• Published: 07/17/2003
• Est. Priority Date: 01/15/2002
• Status: Abandoned Application

• Current Assignee: Alejandro Leali, Joseph F. Fetto
• Original Assignee: Alejandro Leali, Joseph F. Fetto
• Inventors: Leali, Alejandro, Fetto, Joseph F.
• Application Number:
  US10/050,337
• Publication Number:
  US 20030135214A1
• Time in Patent Office: Days
• US Class Current: 606/72
• CPC Class Codes: A61B 17/1615 Drill bits, i.e. rotating tools extending from a handpiece to contact the worked material
• CPC Class Codes: A61B 17/1617 with mobile or detachable parts
• CPC Class Codes: A61B 17/1668 for the upper femur A61B17/164 takes precedence
• CPC Class Codes: A61B 17/86 Pins or screws or threaded wires; nuts therefor A61B17/72 take precedence
• CPC Class Codes: A61B 17/864 hollow, e.g. with socket or cannulated
• CPC Class Codes: A61B 17/8645 Headless screws, e.g. ligament interference screws
• CPC Class Codes: A61B 17/866 Material or manufacture
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable, resorptive for implantable prostheses A61F2210/0004
• CPC Class Codes: A61B 2090/036 abutting on tissue or skin
• CPC Class Codes: A61F 2/28 Bones joints A61F2/30
• CPC Class Codes: A61F 2/4601 for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
• CPC Class Codes: A61F 2002/2817 Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
• CPC Class Codes: A61F 2002/2828 Femoral head
• CPC Class Codes: A61F 2002/2839 Bone plugs or bone graft dowels
• CPC Class Codes: A61F 2002/2853 Humerus
• CPC Class Codes: A61F 2002/2871 Radius
• CPC Class Codes: A61F 2002/2892 Tibia
• CPC Class Codes: A61F 2002/2896 Ulna
• CPC Class Codes: A61F 2002/3085 with a threaded, e.g. self-tapping, bone-engaging surface, e.g. external surface
• CPC Class Codes: A61F 2002/4207 Talar components
• CPC Class Codes: A61F 2002/4289 : Scaphoid or navicular bone
• CPC Class Codes: A61F 2002/4635 : using minimally invasive surgery

Abstract

A vascular necrosis of the hip is a common disease that usually affects a young, active patient population. As the disease progresses the undermined structural integrity of the subchondral bone leads to articular collapse and subsequent osteoarthrosis. The ideal treatment is one that hinders or arrests the progression of the disease averting articular collapse and a joint replacement surgery. Several non-surgical and surgical procedures have been described to treat avascular necrosis: core decompression, osteotomies of the hip, non-vascularized and vascularized bone grafts. The purpose of this paper is to describe a surgical strategy that attempts to address the multiple factors involved in the progression of the disease: deficits in structural support, increased intraosseous pressure and the bone healing process. This is accomplished through a routine core decompression procedure combined with the insertion of two bone interference screws into the subchondral bone of the femoral head to provide structural support and the use of osteoinductive bone allograft (demineralized bone matrix) in an effort to accelerate the bone response. Prospective studies are currently underway to assess long-term outcomes.

Claims

1. A system for treating and/or preventing the complications associated with avascular necrosis in the musculoskeletal system of a human or non-human patient which comprises:

a. identifying the biological site in the musculoskeletal system of said patient in need of said treatment;

b. creating at least one channel from the exterior of said biological site in said musculoskeletal system into or distal to said site in a manner that facilitates access to said site; and

c. inserting into said at least one channel a combination comprising at least (i) a composition comprising an osteoinductive element, an osteoconductive element or both and (ii) a biologically compatible support member which substantially fills said channel and which provides support to the biological site in the musculoskeletal system of said patient pending formation of new bone and vasculature at said site.

2. The system according to claim 1 wherein said composition comprising said osteoinductive element, said osteoconductive element or both, further comprises at least one angiogenic element.

3. The system according to claim 1 wherein said osteoinductive element comprises demineralized bone matrix (DBM), bone morphogenetic protein (BMP), cartilage derived morphogenetic protein (CDMP), bone progenitor cells, a growth factor, or combinations thereof.

4. The system according to claim 1 wherein said osteoconductive element comprises cortical bone chips, cancellous bone chips, chips which have both a cortical and a cancellous nature, mixtures of cortical bone chips and cancellous bone chips, bioactive ceramic, a calcium salt composition, a phosphate salt composition, or combinations thereof.

5. The system according to claim 1 wherein said composition comprises a biologically compatible carrier matrix.

6. The system according to claim 5 wherein said biologically compatible carrier matrix comprises gelatin, hyaluronic acid, glyscosaminoglycan, glycerol, alginate, methacrylate, methyl-methacrylate, or combinations thereof.

7. The system according to claim 1 wherein said site exhibiting avascular necrosis in the musculoskeletal system is located within the head of the femur, in the femoral or tibial condyles or epicondyles, the malleolus of the tibia or fibula, the head or tubercles of the humerus, or either terminus of the radius or ulna, talus, carpal navicular.

8. The system according to claim 1 wherein said biologically compatible support member which substantially fills said channel and which provides support to the biological site in the musculoskeletal system of said patient pending formation of new bone and vasculature at said site comprises a biologically compatible synthetic material, a biologically compatible metal, a cortical shaft of bone, a cancellous shaft of bone, a shaft of bone that comprises both cortical bone and cancellous bone.

9. The system according to claim 8 wherein said biologically compatible support member is in the form of a plug that substantially fills said channel.

10. The system according to claim 9 wherein said plug comprises threading over at least a portion of its circumference such that said plug maybe torqued into place within said channel.

11. The system according to claim 10 wherein said plug comprising threading over at least a portion of its circumference further comprises a means for engagement with a torque delivery mechanism.

12. A kit for treating avascular necrosis in the musculoskeletal system of a human or non-human patient wherein said treating comprises:

a. identifying the biological site in the musculoskeletal system of said patient in need of said treatment;

b. creating at least one channel from the exterior of said biological site in said musculoskeletal system distal or into said site in a manner that facilitates access to said site; and

c. inserting into said at least one channel a combination comprising at least (i) a composition comprising an osteoinductive element, an osteoconductive element or both and (ii) a biologically compatible support member which substantially fills said channel and which provides support to the biological site in the musculoskeletal system of said patient pending formation of new bone and vasculature at said site;

wherein said kit comprises;

i. at least one sterile or sterilizable drill bit for creating said channel;

ii. at least one composition comprising said osteoinductive element, said osteoconductive element or both;

iii. at least one biologically compatible support member; and

iv. at least one device adapted for insertion of said biologically compatible support member into said channel.

13. The kit according to claim 12 wherein said drill bit is cannulated, and has a diameter of between about 5 mm and about 10 mm.

14. The kit according to claim 12 wherein said drill bit comprises at least one steps in its diameter, including in its cutting edge and optionally including an adjustable collar that may be slid axially along the drill bit.

15. The kit according to claim 12 further comprising a tap for inscribing threads within said channel, wherein said tap is cannulated, and has a diameter of between about 5 mm and about 10 mm.

16. The kit according to claim 12 further comprising at least one guidewire.

17. The kit according to claim 12 wherein said device adapted for insertion of said biologically compatible support member into said channel is cannulated

18. The kit according to claim 12 further comprising a delivery device for inserting into said at least one channel said composition comprising an osteoinductive element, an osteoconductive element or both.

19. The kit according to claim 18 wherein said delivery device comprises a tamp, a syringe, or both.

20. The kit according to claim 12 wherein said biologically compatible support member which substantially fills said channel and which provides support to the biological site in the musculoskeletal system of said patient pending formation of new bone and vasculature at said site comprises a biologically compatible synthetic material, a biologically compatible metal, a cortical shaft of bone, a cancellous shaft of bone, a shaft of bone that comprises both cortical bone and cancellous bone.

21. The kit according to claim 20 wherein said biologically compatible support member is in the form of a plug that substantially fills said channel.

22. The kit according to claim 21 wherein said plug comprises threading over at least a portion of its circumference such that said plug may be torqued into place within said channel.

23. The kit according to claim 22 wherein said plug comprising threading over at least a portion of its circumference further comprises a means for engagement with a torque delivery mechanism.

24. The kit according to claim 20 wherein said biologically compatible support member comprises substantially cortical bone.

25. The kit according to claim 24 wherein said substantially cortical bone support member is cannulated.

26. The kit according to claim 24 wherein said substantially cortical bone support member is of a length of about 25 mm to about 35 mm.

27. The kit according to claim 26 wherein said substantially cortical bone support member is at least partially demineralized.

28. The kit according to claim 12 further comprising an instrument tray.

29. A screw made from bone comprising a cylinder of bone, with or without taper, of a length between about 25 mm and about 35 mm, and a width of between about 5 mm and about 10 mm.

30. The screw made from bone according to claim 29 wherein said screw comprises a thread inscribed in the circumference of the screw over at least a portion of the circumference thereof.

31. The screw made from bone according to claim 29 wherein said screw is cannulated.

32. The screw made from bone according to claim 29 wherein said bone is partially or completely demineralized.

33. The screw according to claim 32 wherein said screw has been soaked or infused with growth factors, BMP, bone progenitor cells, or combinations thereof.

34. The screw according to claim 29 comprising cortical bone, cancellous bone, or both cortical and cancellous bone.

35. A method of treating or preventing avascular necrosis in the femur of a human or non-human patient which comprises:

a. Appropriately positioning the patient to provide access to the affected limb;

b. Forming an incision to permit exposure of the aspect of the femur affected by the avascular necrosis;

c. Creating an entry hole in the femur;

d. Inserting at least one guidewire into the femur directed toward the necrotic site and utilizing said guidewire as a guide to create at least one channel directed toward the site of necrosis, which channel may be tapped;

e. Removing said guidewire and introducing into said channel a bone-inducing amount of an osteoinductive substance;

f. Inserting into said channel at least one biocompatible support member; and

g. Closing said incision to permit healing.

36. The method according to claim 35 comprising:

a. Positioning said patient on a fracture table to permit image intensification during the procedure, with the contralateral limb maintained flexed at the hip and abducted;

b. Positioning the affected limb in extension and in sufficient internal rotation to neutralize the anteversion of the femoral neck;

c. Prepping and draping the involved hip for surgery;

d. Forming an approximately 5″

lateral midline incision, dividing the vastus lateralis muscle bluntly along the direction of its fibers in order to achieve subperiosteal exposure of the lateral aspect of the proximal femur;

e. Drilling, under image intensification, an entry hole of between about 7 to 10 millimeters in diameter;

f. Inserting a guide wire into the depth of the subchondral bone;

g. Preparing a canal or channel into the bone with a reamer of about 9 millimeters in diameter introduced to about 80 to 90% of the intended length over the guide wire;

h. Forming the remaining depth of the canal or channel to the subchondral plate with a tap of an about 8 millimeter diameter;

i. Removing the guide wire;

j. Introducing into the canal or channel two to three cubic centimeters of an osteoinductive composition selected from the group consisting of demineralized bone matrix, bone morphogenetic protein, angiogenic factors, cartilage derived growth factor, and combinations thereof;

k. Driving, under image intensification, an allograft or xenograft bone screw into the full depth of the canal;

l. Repeating steps f-k to create a second diverging path and to provide support to a sufficient subchondral area with the use of a second allograft or xenograft bone screw;

m. Packing the remainder of the canal with an osteoconductive or an osteoinductive composition selected from the group consisting of bone chips, demineralized bone matrix, bone morphogenetic protein, angiogenic factors, cartilage derived growth factor, and combinations thereof;

n. Irrigating and closing the surgical wound; and

o. Maintaining the patient on protected weight bearing for approximately 6 weeks after the surgery.